Best Biopharma Outsourcing Companies in Ile de France, France
The 65 best Biopharma Outsourcing companies in Ile de France, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: M2i Life Sciences.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Ile de France
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Aixial Provider of pharmaceutical consulting services | — | — | 1,000 | 2004 | — | — | — | — |
| 2 | AxPharma Provider of vigilance, case treatment, and medical writing services for life science companies | — | — | 41 | 2001 | — | — | — | — |
| 3 | Azur Health Science Provider of medical writing services for biopharma sector | — | — | — | 2017 | — | — | — | 1 launch |
| 4 | Biogaran Provider of software development services for biopharma sector | — | — | 225 | 1996 | — | DrupalApple iCloud MailMicrosoft 365+16 | 6 patents Smart medication dose housing and adherence monitoring systems | — |
| 5 | BrainPlotting Provider of human blood brain barrier models for pharmacokinetic, toxicological and pharmacological testing | — | — | 2 | 2013 | Nicolas Perriere Founder & CEO | — | — | — |
| 6 | CELLforCURE Developer of cell and gene therapy products | — | — | 153 | 2010 | — | — | — | — |
| 7 | CEPTON Provider of healthcare consulting services | — | — | 35 | 2013 | — | WordPressMySQLPHP+17 | — | — |
| 8 | CLINACT Functional services for clinical research | — | — | — | 1996 | Gerard Sorba CEO & President | — | — | 1 job opening |
Top 12 Biopharma Outsourcing companies in Ile de France
#1
Series A · Paris, Ile de France · founded 2022$5.5Mraised▾
Provider of drugs discovery services
- Apr 2026Series A$23.3M
- Oct 2024Seed$5.5M
#2
Seed · Villejuif, Ile de France · founded 2023$3.1Mraised▾
Orakl Oncology is a precision oncology start-up that partners with Gustave Roussy, one of the world's top cancer centers, to connect patient tumors and enable the emergence of rare oncology. They have recently raised €3 million to develop their techbio platform for precision oncology.
- Dec 2024Seed$11.6M
- Oct 2023Seed$3.1M
#3
Seed · Paris, Ile de France · founded 2020 · 3 employees$7.1Mraised▾
BIOPHTA is a pharmaceutical platform founded in 2020 that aims to improve the efficacy of eye treatments. The company has developed an ophthalmic insert to simplify eye treatment for patients with eye diseases.
- Jun 2024Seed$7.1M
#4
Series B · Saint Cloud, Ile de France · founded 2012 · 200 employees$79.4Mraised▾
M2I Life Sciences offers APIs, pheromones for crop protection and animal health. The company is focusing on three businesses namely pharma, veterinary and agriculture. They provide custom synthesis and contract manufacturing services. The company synthesizes pheromonal molecules. They also offer chemicals such as ceramides, antioxidants, alkylglycerols, etc.
- Sep 2019Series B$66M
- Jun 2017Series A$13.4M
#5
Public · Paris, Ile de France · founded 1993$17.9Mraised▾
CDMO focused on manufacturing of vaccines
- Dec 2018Post IPO$2.6M
- Jun 2017Post IPO$4.1M
- Jun 2016Post IPO$9.1M
- Jul 2015Post IPO$8.3M
#6
Acquired · Fontenay sous Bois, Ile de France · founded 2004 · 1372 employees$937.9Kraised▾
Pharmaceutical contract development and manufacturing providing pre-formulation and formulation services. The company also provides services for pre-formulation and formulation in a variety of dosage forms including sterile and solid dosage forms. Its facilities are approved by FDA, EMEA, PMDA and ANVISA.
- Sep 2023Grant (prize money)$492K
- Feb 2023Grant (prize money)$163.1K
- Jun 2022Grant (prize money)$282.8K
- Sep 2015Conventional Debt—
#7
Funding Raised · Paris, Ile de France · founded 2001$3.7Mraised▾
Provider of R&D funding program consulting and project management services. It advises companies and research bodies on research funding and project management. The company supports project proposals, partner searches, collaborative proposal writing, and contractualization. It also provides support in project management, communication, training, data management, and exploitation of project results.
- Jan 2021Grant (prize money)$217.3K
- Oct 2020Grant (prize money)$246.6K
- Jan 2020Grant (prize money)$264.2K
- Jan 2020Grant (prize money)$758.5K
#8
Funding Raised · Paris, Ile de France · founded 2016 · 30 employees$1.8Mraised▾
Digital animal brain imaging and analysis device for researchers. The company has developed functional neuroimaging systems for preclinical neuroscience research and drug discovery industries. They have developed an imaging modality based on blood flow imaging. It enables to detection of neuronal activation in the whole brain.
- Oct 2022Grant (prize money)$1.2M
- Jan 2020Grant (prize money)$647.6K
#9
Acquired · Paris, Ile de France · founded 1993 · 2000 employees$903.7Kraised▾
Unithers is a contract manufacturing organization specializing in various dosage forms. Technologies offered include blow-fill seals, liquid stick packs, powder stick packs, effervescent tablets, pharmaceutical bottles, and suppositories and pessaries. The company claims to have R&D and manufacturing in Europe, a manufacturing facility in North America, and sales offices in Brazil.
- Oct 2022Series C—
- Dec 2021Grant (prize money)$903.7K
- Mar 2017Conventional Debt—
- Nov 2011Conventional Debt—
#10
Funding Raised · Paris, Ile de France · founded 2015$1.6Mraised▾
Provider of clinical research services for biopharma sector
- Sep 2020Grant (prize money)$807.8K
- Dec 2018Grant (prize money)$387.7K
- Jan 2018Grant (prize money)$417.9K
#11
Funding Raised · Vert le Petit, Ile de France · founded 2017 · 230 employees$897.3Kraised▾
Pmc Isochem offers cGMP, non-cGMP custom synthesis and customized services from development to production, including route selection, analytical development as well as process optimization. The services include clinical batch supply, routine production, regulatory support and risk management. The company also offers N-CarboxyAnhydrides for the polypeptide synthesis. They have FDA certified production sites and has collaboration with Polypeptides Therapeutic Solutions. The company offers support for IND filing.
- Feb 2022Grant (prize money)$897.3K
#12
Funding Raised · Paris, Ile de France · founded 1988 · 6000 employees$969Kraised▾
Delpharm provides contract manufacturing services for pharmaceutical products. It's product offering includes licensed products, generics, OTC products, dietary supplements, and veterinary products. The company has built capacity in various finished dosage forms including solid forms, such as tablets, pills, film coated tablets, effervescent, granulates, pouches, and capsules; semi-solid forms, including gels, creams, suppositories, and ointments; liquid forms, which include syrups, drops, ampoules, pouches, injected pouches, and vials; and specialty products that comprise cytotoxics, injectable steriles, biotechnologies, barium products, hormone gels, cell cultures, and diagnostic kits. It also offers various packaging solutions. The currently operate 10 manufacturing plants across various locations in France.
- Jun 2021Grant (prize money)$969K
- Feb 2016Conventional Debt—
- Jul 2011Conventional Debt—
- Jun 2011Conventional Debt—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in France
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,220 France-affiliated papers.
- Centre National de la Recherche Scientifique280
- Inserm169
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement144
- Ministry of Agriculture118
- AgroParisTech36
- Gene3→26
- Genome2→14
- Antibody1→10
- Cell culture1→10
- Mutant1→10
- Gene2→30
- Agriculture1→20
- Selection (genetic algorithm)2→18
- Resistance (ecology)2→16
- Population1→12
- Agriculture2→13
- Antibiotic resistance3→12
- Population1→9
- Public health1→8
- Context (archaeology)2→9
Where biotechnology is researched across France
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in France
France biotechnology patent filing is cooling — 34,222 filings from 8,000 assignees (2016–2025), led by Centre NAT RECH Scient, INST NAT Sante RECH MED, Sanofi; annual filings 3501→2745.
- Centre NAT RECH Scient10040
- INST NAT Sante RECH MED8292
- Sanofi3990
- Pasteur Institut3416
- Agronomique INST NAT RECH1331
- Cellectis1320
- PF Medicament1203
- Commissariat Energie Atomique1151
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.